Back to Market返回行情

SRTS Sensus Healthcare, Inc.

USHealthcare
$3.05+4.45%ClosedMarket Cap: $50.2M

As of 2026-07-10 16:00

Why SRTS matters now

Sensus Healthcare, Inc. (SRTS) is a US stock in Healthcare. The latest InvestLog snapshot shows $3.05 with +4.45% on the session and $50.2M in market capitalization; recent performance reads 1-month -16.72% and YTD -29.90%.

The latest financial table shown here is Q1 2026, with revenue of $3.4M, net income of $-2.6M, and EPS of $-0.16. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -1.4%.

The latest indexable market news headline is "Sensus Healthcare Q1 Earnings Call Highlights" from MarketBeat.

Additional event context on this page matters because analyst consensus is Buy with a median target of $6.25; recent insider activity includes Sachetta Eric filing P-Purchase. These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

PEG

P/B

1.01

P/S

2.04

EV/EBITDA

-3.50

DCF Value

$3.21

FCF Yield

-1.4%

Div Yield

0.0%

Margins & Returns

Gross Margin

37.7%

Operating Margin

-53.3%

Net Margin

-34.5%

ROE

-15.8%

ROA

-15.1%

ROIC

-17.8%

Financials

PeriodRevenueNet IncomeEPS
Q1 2026$3.4M$-2.6M$-0.16
Q4 2025$4.9M$-3.2M$-0.19
FY 2025$27.5M$-7.7M$-0.47
Q3 2025$6.9M$-943.0K$-0.06

Analyst Ratings

Consensus

Buy

Target (Consensus)

$6.25

Target (Median)

$6.25

Target Range

$6.00 - $6.50

Strong Buy: 1Buy: 3Hold: 0Sell: 0Strong Sell: 0
Maxim GroupBuy
2026-02-17
HC Wainwright & Co.Buy
2025-08-12
Lake StreetBuy
2025-08-08

Trading Activity

Insider Trades

Sachetta Ericdirector
Buy2026-05-12
Sachetta Eric
Sell2026-04-23
Martinez Magdalenaofficer: CHIEF OPERATING OFFICER
Sell2026-04-22
Martinez Magdalenaofficer: CHIEF OPERATING OFFICER
Sell2026-04-22
Rampolla Javierofficer: CHIEF FINANCIAL OFFICER
Sell2026-04-22

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

Beta

1.09

Sensus Healthcare, Inc. operates as a medical technology enterprise, manufacturing and distributing radiation therapy apparatuses to medical institutions across the globe. The company's portfolio leverages superficial radiation therapy (SRT), a cutting-edge low-energy X-ray methodology. Their product line features the SRT-100, a photon X-ray system for low-energy superficial radiotherapy. This device presents a non-surgical alternative for patients dealing with non-melanoma skin cancers, including basal cell and squamous cell carcinomas, alongside other dermatological issues like keloids. Another key offering is the SRT-100 Vision, which incorporates a specialized SRT treatment planning application. This application seamlessly integrates an embedded high-frequency ultrasound imaging module, tools for volumetric tumor analysis, beam margin delineation, and dosimetry parameter configuration. In addition, Sensus Healthcare provides the SRT-100 Plus, the Sentinel service program to ensure system protection for its clients, and options for in-office laser rentals. They also supply various consumable items, such as replacement lead shielding, disposable radiation safety gear like aprons and eye shields, ultrasound probe film, and single-use applicator tips designed to treat lesions of different sizes and on various body areas. Founded in 2010, Sensus Healthcare, Inc. maintains its corporate headquarters in Boca Raton, Florida.